Jump to navigation Jump to search
This article is a stub.
As such, it may contain incomplete or wrong information. You can help by expanding it.
Psychedelic therapy refers to therapeutic practices involving the use of psychedelic drugs, particularly serotonergic psychedelics such as LSD, psilocybin, DMT, and 2C-B, primarily to assist psychotherapy. As an alternative to synonyms such as "hallucinogen", "entheogen", "psychotomimetic" and other functionally constructed names, the use of the term psychedelic ("mind-manifesting") emphasizes that those who use these drugs as part of a therapeutic practice believe these drugs can facilitate beneficial exploration of the psyche.
A small number of therapists continue to use MDMA in therapy despite its illegal status.
List of substances researched in psychedelic therapy
- Psychedelic therapy (Wikipedia)
- Legalizing Psychedelic Therapy (Indiegogo)
- MDMA-Assisted Psychotherapy (MAPS)
- Handbook For The Therapeutic Use Of Lysergic Acid Diethylamide-25 (MAPS)
- MDMA-Assisted Psychotherapy Treatment Manual (MAPS)
- ↑ Levy, Enno Freye ; in collaboration with Joseph V. (2009). Pharmacology and abuse of cocaine, amphetamines, ecstasy and related designer drugs a comprehensive review on their mode of action, treatment of abuse and intoxication (Online-Ausg. ed.). Dordrecht: Springer Netherlands. p. 152. ISBN 9789048124480.
- ↑ Naranjo, C.; Shulgin, A. T.; Sargent, T. (1967). "Evaluation of 3, 4-methylenedioxeamphetamine (MDA) as an adjunct to psychotherapy". Pharmacology. 17 (4): 359–364. doi:10.1159/000137100.
- ↑ Yensen, R.; Di Leo, F. B.; Rhead, J. C.; Richards, W. A.; Soskin, R. A.; Turek, B.; Kurland, A. A. (1976). "MDA-assisted psychotherapy with neurotic outpatients: a pilot study". The Journal of Nervous and Mental Disease. 163 (4): 233–245. doi:10.1097/00005053-197610000-00002. PMID 972325.